Sites / Palm Beach Research Center
Is this you?

Request access for Palm Beach Research Center with your @palmbeachresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Palm Beach Research Center

Unclaimed profile

Independent Network · West Palm Beach, FL · ~1 sites

Intera lens
ICP 4Lift (cardio sample) 0.07Recruit soph 0.43
Quality Scorecard (1–100)
Overall83Recruit75Ops84Sponsor91Ther85

Performance (observed)

Historical trials
476
Completed
319
Terminated/Withdrawn
75
Completion rate
81%
Active now
72
Phase 2
134
Phase 3
275
Realized enrollment
753,018
First study year
1994
Years active
32
Match confidence
high
Enrollment velocity (inf)
23,532

Therapeutic

Areas
Multi-therapeutic (111 total trials completed)
Specialties
Dermatology, Endocrinology, Gastroenterology, Infectious Disease, Neurology, Women's Health, Psychiatry, Urology, Rheumatology, Pulmonology, Phase I
Breadth (conditions)
429
Languages
English + Spanish (detected)
States
FL

Recruitment (web observed)

Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Y (minimal organic presence; basic capabilities page)
Capability notes
Full-service trial management; partnerships with sponsors/CROs; medical director oversight; quality-focused

Relationships

Sponsors
Eli Lilly and Company; Pfizer; AbbVie; Allergan; Alliance for Clinical Trials in Oncology; Boehringer Ingelheim
CROs
ICON Clinical Research; MacroGenics; Medpace, Inc.; PPD Development, LP; PRA Health Sciences; Parexel
Owner / parent
Independently owned

Capacity & people

Investigators
Coordinators
CEO
David Scott, MBA, CCRC (President & CEO)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
info@palmbeachresearch.com

Tech & DCT

eSource
Yes
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y

Notes

Operating since 1994 (30+ years). Single location in West Palm Beach. 111 completed trials demonstrate strong execution history. Multi-therapeutic platform. CEO David Scott (MBA, CCRC). Limited scale and growth trajectory visibility.

Recommendation features (sample indication)

Ind fit 0.12Liftability 0.07Overall83

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.